Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Cancer: A Meta-Analysis

Table 1

The characteristics of included studies.

Study (year)	Country	Cancer type	Sample capacity	Age (years)	Gender ratio	Treatment	Outcome	Follow-up (months)	Cutoff value	Analysis	NOS
Nie et al. [11]	China	Metastatic NPC	209	Median 45 (14-72)	179/30	With chemotherapy	OS, PFS	Median 16.6 (1-66.6)	0.447	M	8
Cai et al. [18]	China	Advanced HCC	237	Median 56 (45-66)	206/31	Without standard treatment	OS	>12	0.38	M	8
Chen et al. [10]	China	HCC	372	Median 52 (44-61)	348/24	With chemotherapy	OS	>60	0.439	M	8
			202	Median 56 (45-65)	176/26	With chemotherapy	OS	>60	0.439	M	8
			82	Median 55 (44-63)	73/9	With chemotherapy	OS	>60	0.439	M	8
Tan et al. [13]	China	UTUC	692		398/294	With surgery	OS, CSS, RFS	Median 42 (20-75)	0.58	M	8
Long et al. [14]	China	Nonmetastatic breast cancer	746	NA	0/746	With surgery	OS	>60	0.525	M	8
Kim et al. [19]	Korea	Nonmetastatic NPC	100	NA	78/22	Mixed	OS, PFS, LRRFS, DMFS	Median 50.6	0.4876	M	8
Li et al. [15]	China	Metastatic NSCLC	290	Mean 55 (25-90)	210/75	With chemotherapy	OS	>60	0.84	M	8
Li et al. [20]	China	Lung cancer	390		243/147	With surgery	OS, DFS	Median 50.0 (12-66)	0.57	M	8
Li et al. [21]	China	Limited stage SCLC	122	Median 58	244/58	With radiotherapy	OS, PFS	Median 21.3 (17.9-25.2)	0.61	U	6
Xia et al. [22]	China	Nonmetastatic RCC	419		266/153	With surgery	OS, CSS	Median 50.0 (30.4-83.0)	0.39	M	8
			204		127/77	With surgery	OS, CSS	Median 50.2 (29.8-83.1)	0.39	U	6
Xiong et al. [23]	China	CCA	303	Median 59 (29-83)	168/135	With surgery	OS, PFS	Median 21.0	0.41	M	8
Zhang et al. [24]	China	Cervical carcinoma	230	Median 55 (29-79)	101/65	With surgery	OS, DFS	Median 81 (12-137)	0.68	M	8
Zhang et al. [12]	China	NSCLC	496	Median 60 (34-81)	334/162	With surgery	OS, DFS	Median 47.0 (2.0-96.0)	0.64	M	8
Li et al. [25]	China	HCC	149	Mean 51.26	141/8	With surgery	OS, RFS	>60	0.38	U and M	7
			61	Mean 52.15	57/4	With surgery	OS, RFS	>60	0.38	U	6
Li et al. [26]	China	HCC	188	Median 52.3 (22-77)	161/27	With surgery	OS, RFS	Median 46.5	0.4	M	8
Zhou et al. [27]	China	ED-SCLC	224		197/27	Mixed	OS	NA	0.35	M	8